Exploring Half-Dose DOAC Therapy to Prevent DRT and Reduce Bleeding Risk
On October 13, 2021, a prospective, non-randomized study published in JACC Intervention indicated that after successful left atrial appendage closure (LAAC) using the WATCHMAN device (Boston Scientific), an anticoagulation strategy centered on half-dose direct oral anticoagulants (DOAC) might improve overall surgical outcomes and reduce the occurrence of device-related thrombosis (DRT) compared to standard anticoagulation therapy … Read more